Incidence and distribution of HER2-positive gastric and gastroesophageal junction (GEJ) adenocarinomas in British Columbia (BC)

被引：0
|
作者：
Lim, H. J.
Aubin, F.
Kollmannsberger, C. K.
Huntsman, D.
Carter, B.
Zhou, C.
Woods, R.
Gill, S.
机构：
[1] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada
[2] Ctr Hosp Univ Montreal, Montreal, PQ, Canada
[3] British Columbia Canc Agcy, Vancouver Canc Ctr, Vancouver, BC V5Z 4E6, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 04期
关键词：
D O I：
10.1200/jco.2011.29.4_suppl.91
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
91
引用
收藏
页数：1
相关论文
共 50 条
  • [21] HER2-positive gastric cancer
    Boku, Narikazu
    GASTRIC CANCER, 2014, 17 (01) : 1 - 12
  • [22] HER2-Positive Gastric Cancer
    Haralabos Demetriades
    Annals of Surgical Oncology, 2011, 18 : 190 - 191
  • [23] HER2-positive gastric cancer
    Narikazu Boku
    Gastric Cancer, 2014, 17 : 1 - 12
  • [24] Evolving Landscape of Targeted Treatment Options for HER2-Positive Gastric/Gastroesophageal Adenocarcinomas
    Epistola, Raisa
    Chao, Joseph
    Lee, Jennifer
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2023, 21 (06) : 312 - 320
  • [25] A phase II trial of [fam-] trastuzumab deruxtecan (T-DXd, DS-8201a) in subjects with HER2-positive, unresectable, or metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma
    Fuchs, Charles S.
    Shahidi, Javad
    Mathew, Lijoy
    Qin, Amy
    Van Cutsem, Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [26] Q-TWiST analysis of pembrolizumab plus trastuzumab and chemotherapy for patients with metastatic HER2-positive gastric or gastroesophageal junction (G/GEJ) adenocarcinoma in the KEYNOTE-811 trial.
    Rha, Sun Young
    Revil, Cedric
    Valderrama, Adriana
    Wang, Liya
    Andre, Manon
    McCarthy, Grant
    Young, Kate
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 354 - 354
  • [27] Phase 2 study of trastuzumab deruxtecan as neoadjuvant treatment for HER2-positive gastric and gastroesophageal junction adenocarcinoma (EPOC2003).
    Takahari, Daisuke
    Kawazoe, Akihito
    Machida, Nozomu
    Minashi, Keiko
    Yamagata, Yukinori
    Hara, Hiroki
    Omori, Takeshi
    Yamamoto, Manabu
    Yasui, Hisateru
    Nakayama, Izuma
    Yamada, Takanobu
    Kano, Masayuki
    Yoshikawa, Takaki
    Wakabayashi, Masashi
    Komura, Yu
    Sato, Akihiro
    Kuwata, Takeshi
    Kojima, Motohiro
    Kinoshita, Takahiro
    Shitara, Kohei
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 309 - 309
  • [28] Costs of Trastuzumab in Combination With Chemotherapy for HER2-Positive Advanced Gastric or Gastroesophageal Junction Cancer: An Economic Evaluation in the Chinese Context
    Wu, Bin
    Ye, Ming
    Chen, Huafeng
    Shen, Jinfang F.
    CLINICAL THERAPEUTICS, 2012, 34 (02) : 468 - 479
  • [29] Progress and challenges in HER2-positive gastroesophageal adenocarcinoma
    Dan Zhao
    Samuel J. Klempner
    Joseph Chao
    Journal of Hematology & Oncology, 12
  • [30] Progress and challenges in HER2-positive gastroesophageal adenocarcinoma
    Zhao, Dan
    Klempner, Samuel J.
    Chao, Joseph
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2019, 12 (1)
12345